HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Göppner Selected Research

Cholangitis

4/2015Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Göppner Research Topics

Disease

13Melanoma (Melanoma, Malignant)
11/2023 - 01/2011
6Neoplasms (Cancer)
01/2016 - 07/2010
3Neoplasm Metastasis (Metastasis)
11/2023 - 04/2015
3Skin Neoplasms (Skin Cancer)
01/2017 - 01/2016
1Cytokine Release Syndrome
10/2021
1Exanthema (Rash)
01/2021
1Bullous Pemphigoid (Pemphigoid)
01/2020
1Disease Progression
01/2016
1Hepatocellular Carcinoma (Hepatoma)
04/2015
1Cholangitis
04/2015
1Atopic Dermatitis (Atopic Eczema)
03/2013
1Basal Cell Carcinoma (Rodent Ulcer)
01/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2010

Drug/Important Bio-Agent (IBA)

3VemurafenibIBA
11/2023 - 09/2014
3pembrolizumabIBA
10/2021 - 01/2016
3IpilimumabIBA
01/2017 - 01/2013
2cobimetinibIBA
11/2023 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2017 - 01/2016
2NivolumabIBA
01/2016 - 01/2016
2AntibodiesIBA
01/2016 - 01/2016
1encorafenibIBA
10/2021
1binimetinibIBA
10/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1TransferasesIBA
10/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1AutoantibodiesIBA
01/2020
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2017
1Monoclonal AntibodiesIBA
01/2017
1Interferon alpha-2 (Roferon-A)FDA Link
12/2015
1GlobulinsIBA
03/2013
1Omalizumab (Xolair)FDA Link
03/2013
1Cetuximab (Erbitux)FDA Link
10/2010
1denileukin diftitox (Ontak)FDA Link
07/2010

Therapy/Procedure

9Therapeutics
11/2023 - 07/2010
2Aftercare (After-Treatment)
01/2021 - 04/2015
1Drug Tapering
01/2021
1Immunotherapy
01/2017
1Brachytherapy
04/2015
1Radiofrequency Ablation
04/2015
1Radioimmunotherapy
07/2010